Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission
Clinical trial NCT02632396 · UNKNOWN
Trial details
- NCT number
- NCT02632396
- Sponsor
- Emory University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2023-08-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.